Apolipoprotein E: Emerging Story in the Pathogenesis of Alzheimer's Disease
- 1 September 1995
- journal article
- research article
- Published by SAGE Publications in The Neuroscientist
- Vol. 1 (5) , 298-306
- https://doi.org/10.1177/107385849500100507
Abstract
Apolipoprotein E (apoE) is implicated in the pathogenesis of Alzheimer's disease. One of the three com mon apoE alleles, apoE4, behaves as an autosomal codominant trait in the majority of late-onset and sporadic Alzheimer's disease, with homozygosity for this allele virtually sufficient to cause disease by the age of 80. In contrast, the apoE2 and apoE3 alleles decrease the probability of disease and increase the age of onset, with the protective effect of apoE2 greater than apoE3. Thus, the inherited alleles of apoE determine, in part, the risk of developing Alzheimer's disease and determine the rate of disease progres sion. Isoform-specific interactions of apoE with other molecules are therefore critical in this disease. ApoE is found in populations of neurons, some of which contain abnormal neurofibrillary tangles assembled from the protein tau. In healthy neurons, tau helps assemble and stabilize microtubules, but in Alzheimer's disease, it forms paired helical filaments of the neurofibrillary tangle. ApoE3 avidly binds tau in vitro, whereas apoE4 does not. Isoform-specific interactions of apoE with tau and other microtubule-associated proteins could contribute to the mechanism of Alzheimer's disease. Uncovering the roles of apoE in the brain, both in health and in disease, will be an exciting area for neuroscience. The Neuroscientist 1:298- 306, 1995Keywords
This publication has 44 references indexed in Scilit:
- Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's diseaseNeuroscience Letters, 1994
- Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium?Annals of Neurology, 1994
- Clinical application of apolipoprotein E genotyping to Alzheimer's diseaseThe Lancet, 1994
- Confirmation of association between the e4 allele of apolipoprotein E and Alzheimer's disease.Journal of Medical Genetics, 1994
- Complex Genetic Disease: Can Genetic Strategies in Alzheimer's Disease and New Genetic Mechanisms Be Applied to Epilepsy?Epilepsia, 1994
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactionsNeuron, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- An ‘anatomical cascade hypothesis’ for Alzheimer's diseaseTrends in Neurosciences, 1992
- Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's diseaseNeuroscience Letters, 1992